< Back to companies

Scinvivo enables optical biopsy for bladder cancer diagnostics. Current imaging techniques for bladder cancer have their limitations, as they only enable the urologist to visualise the bladder wall surface. In 30% of the cases, healthy tissue is incorrectly classified as cancerous. Another limitation is that it is difficult to fully remove a tumor during a surgical procedure, as the borders of the tumor are difficult to visualize. The last limitation is that it is impossible to determine the invasion depth of the tumor with current imaging technologies, while the invasion depth has major impact on the proposed treatment. All these limitation lead to unnecessary, invasive, and costly interventions. Scinvivo'ss technology enables the urologist to improve diagnosis, and thus decreasing the amount of interventions, patient burden, and costs.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
www.scinvivo.com/

Categories

Imaging DiagnosticsDiagnosticsCancer CareUrology

Disease Areas

Technologies

Medical ImagingDiagnostic ImagingImage Processing & Reconstruction
Only accessible to MedStartr community members. Join now

What do you think of Scinvivo?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now